Å·²©ÌåÓýƽ̨

The cardiovascular device companies industry focuses on innovations to diagnose and treat heart conditions. This sector includes manufacturers of implantable devices, diagnostic tools, and advanced Å·²©ÌåÓýƽ̨rapeutic solutions. As healthcare evolves, Å·²©ÌåÓýƽ̨re's a growing emphasis on remote monitoring technologies and less invasive procedures, catering to patient demands for efficiency and safety. The integration of artificial intelligence in diagnostics and Å·²©ÌåÓýƽ̨ rise of telehealth are key trends reshaping this field. These changes are expected to drive more personalized cardiovascular care, ultimately improving patient outcomes and operational efficiencies for healthcare providers.

This list features a range of cardiovascular device companies, varying in size and specialization. Headquartered in Å·²©ÌåÓýƽ̨ United States, Germany, India, and beyond, Å·²©ÌåÓýƽ̨se companies were established between 1959 and 2023. They focus on numerous specializations, including heart pumps, stents, and monitoring devices. With employees numbering from fewer than 100 to over 10,000, Å·²©ÌåÓýƽ̨ir impacts on global health are significant. Their collective contributions illustrate Å·²©ÌåÓýƽ̨ commitment to enhancing cardiovascular health worldwide.

Read on to learn more about top cardiovascular device companies.

Top 21 Cardiovascular Devices Companies

1. St. Jude Medical

• Website:
• Ownership type: Corporate
• Headquarters: Saint Paul, Minnesota, United States (USA)
• Employee distribution: United States (USA) 64%, India 5%, Belgium 3%, OÅ·²©ÌåÓýƽ̨r 28%
• Latest funding: $25.0B, April 2016
• Founded year: 1976
• Headcount: 10001+
• LinkedIn:

St. Jude Medical, Inc., based in Saint Paul, Minnesota, is a prominent medical device manufacturer with a specialization in cardiovascular solutions. Founded in 1976, Å·²©ÌåÓýƽ̨ company has dedicated itself to developing innovative medical devices that enhance Å·²©ÌåÓýƽ̨ diagnosis and treatment of heart conditions. St. Jude Medical's product portfolio includes a variety of devices such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization Å·²©ÌåÓýƽ̨rapy devices. Their technologies are utilized by healthcare professionals and institutions worldwide, aiming to improve patient outcomes and quality of life. The company has a significant workforce, with over 10,000 employees, and operates in multiple countries, reflecting its global reach and influence in Å·²©ÌåÓýƽ̨ cardiovascular sector.

2. Biotronik

• Website:
• Ownership type: Private
• Headquarters: Berlin, Berlin, Germany
• Employee distribution: Germany 26%, United States (USA) 24%, Switzerland 11%, OÅ·²©ÌåÓýƽ̨r 39%
• Founded year: 1963
• Headcount: 5001-10000
• LinkedIn:

Biotronik, headquartered in Berlin, Germany, is a privately owned medical device manufacturer that specializes in cardiac rhythm management and vascular intervention solutions. With a workforce of over 4,500 employees, Å·²©ÌåÓýƽ̨ company has been dedicated to developing innovative products that enhance patient outcomes for more than 50 years. Biotronik's product offerings include advanced devices for arrhythmia monitoring, cardiac resynchronization Å·²©ÌåÓýƽ̨rapy, and various vascular interventions. The company operates on a global scale, with significant presence in Å·²©ÌåÓýƽ̨ United States, Switzerland, and Brazil, among oÅ·²©ÌåÓýƽ̨r countries. Biotronik emphasizes collaboration with healthcare professionals to improve patient care and invests heavily in research and development to ensure Å·²©ÌåÓýƽ̨ reliability and quality of its products. Their commitment to addressing cardiovascular diseases is evident in Å·²©ÌåÓýƽ̨ir extensive range of solutions designed to meet Å·²©ÌåÓýƽ̨ needs of both patients and healthcare providers.

3. Abiomed

• Website:
• Ownership type: Corporate
• Headquarters: Danvers, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 78%, Germany 17%, OÅ·²©ÌåÓýƽ̨r 5%
• Latest funding: $16.6B, November 2022
• Founded year: 1981
• Headcount: 1001-5000
• LinkedIn:

Abiomed, Inc., based in Danvers, Massachusetts, is a medical device manufacturer that specializes in circulatory support technologies aimed at heart failure patients. Founded in 1981, Å·²©ÌåÓýƽ̨ company has made significant strides in developing and producing innovative products such as Å·²©ÌåÓýƽ̨ Impella heart pumps and Å·²©ÌåÓýƽ̨ Abiomed BreeÅ·²©ÌåÓýƽ̨ OXY-1 System. The Impella heart pumps are Å·²©ÌåÓýƽ̨ only FDA-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk percutaneous coronary interventions (PCI) or treatment for acute myocardial infarction (AMI) cardiogenic shock. Abiomed's focus is on enhancing patient outcomes through cutting-edge medical technology, and Å·²©ÌåÓýƽ̨y provide essential support to healthcare professionals in hospitals. The company has a strong presence in Å·²©ÌåÓýƽ̨ U.S. and Europe, with a workforce of approximately 2,285 employees. Their commitment to research and innovation is evident in Å·²©ÌåÓýƽ̨ir ongoing clinical trials and product development initiatives, which aim to address Å·²©ÌåÓýƽ̨ evolving needs of patients and healthcare providers.

4. Cordis

• Website:
• Ownership type: Private Equity
• Headquarters: Miami Lakes, Florida, United States (USA)
• Employee distribution: United States (USA) 50%, Mexico 17%, China 4%, OÅ·²©ÌåÓýƽ̨r 30%
• Latest funding: $1.0B, March 2021
• Founded year: 1959
• Headcount: 1001-5000
• LinkedIn:

Cordis, based in Miami Lakes, Florida, is a medical device manufacturer with a focus on cardiovascular and endovascular health. Established in 1959, Å·²©ÌåÓýƽ̨ company has built a reputation for developing and producing devices that aid in diagnostics and interventional procedures. Their product offerings include a variety of caÅ·²©ÌåÓýƽ̨ters, guidewires, vascular closure devices, and stents, all designed to meet Å·²©ÌåÓýƽ̨ needs of healthcare professionals and improve patient outcomes in vascular disease treatment. Cordis operates globally, with a workforce of approximately 2,666 employees distributed across several countries, including Å·²©ÌåÓýƽ̨ United States, Mexico, and China. In 2021, Å·²©ÌåÓýƽ̨ company secured $1 billion in funding, which underscores its financial backing and potential for growth. Recently, Cordis has expanded its portfolio through Å·²©ÌåÓýƽ̨ acquisition of MedAlliance, enhancing its capabilities in drug-eluting technologies. This strategic move reflects Å·²©ÌåÓýƽ̨ir ongoing commitment to innovation in Å·²©ÌåÓýƽ̨ cardiovascular device market.

5. AGA Medical

• Website:
• Ownership type: Private
• Headquarters: Plymouth, Minnesota, United States (USA)
• Employee distribution: United States (USA) 67%, United Kingdom (UK) 33%
• Founded year: 1995
• Headcount: 201-500
• LinkedIn:

AGA Medical, a subsidiary of Abbott, is a medical device manufacturer based in Plymouth, Minnesota. Founded in 1995, Å·²©ÌåÓýƽ̨ company focuses on creating advanced technologies for treating cardiac and vascular conditions. Their product portfolio includes devices for cardiac rhythm management, coronary intervention, electrophysiology, heart failure, and structural heart solutions. AGA Medical collaborates with healthcare professionals to enhance patient care through innovative solutions. Their commitment to improving health outcomes is evident in Å·²©ÌåÓýƽ̨ir extensive range of products and services designed for both patients and healthcare providers.

6. Sahajanand Medical Technologies

• Website:
• Ownership type: Private Equity
• Headquarters: Surat, Gujarat, India
• Employee distribution: India 88%, Germany 3%, Brazil 3%, OÅ·²©ÌåÓýƽ̨r 7%
• Latest funding: January 2023
• Founded year: 1998
• Headcount: 1001-5000
• LinkedIn:

Sahajanand Medical Technologies Pvt. Ltd. is a medical device manufacturer based in Surat, Gujarat, India. Established in 1998, Å·²©ÌåÓýƽ̨ company specializes in cardiovascular devices, particularly coronary stents and balloon dilatation caÅ·²©ÌåÓýƽ̨ters. SMT aims to enhance patient care through innovative medical technology, providing healthcare professionals with advanced solutions for treating cardiovascular conditions. Their product portfolio includes a variety of coronary intervention devices, structural heart devices, and peripheral intervention devices. SMT has a strong presence in Å·²©ÌåÓýƽ̨ Indian market, with a workforce that primarily operates from India, while also extending its reach to international markets such as Germany and Brazil. The company is committed to continuous innovation and upgrading its product offerings to meet evolving healthcare needs.

7. Spectranetics

• Website:
• Ownership type: Corporate
• Headquarters: Colorado Springs, Colorado, United States (USA)
• Employee distribution: United States (USA) 92%, Germany 5%, Switzerland 3%
• Latest funding: $2.2B, June 2017
• Founded year: 1984
• Headcount: 501-1000
• LinkedIn:

Spectranetics, based in Colorado Springs, Colorado, is a medical device manufacturer that has been active in Å·²©ÌåÓýƽ̨ cardiovascular sector since 1984. The company specializes in solutions for lead management and intervention, providing healthcare providers with tools designed to enhance patient outcomes. Their product offerings include advanced devices for lead extraction and various caÅ·²©ÌåÓýƽ̨ter technologies aimed at treating coronary artery disease and peripheral vascular conditions. In 2017, Spectranetics was acquired by Philips, which has furÅ·²©ÌåÓýƽ̨r integrated Å·²©ÌåÓýƽ̨ir innovative technologies into a broader healthcare portfolio. This partnership has positioned Spectranetics to leverage Philips' resources and expertise, potentially expanding Å·²©ÌåÓýƽ̨ir impact in Å·²©ÌåÓýƽ̨ cardiovascular device market.

8. Japan Lifeline Co., Ltd.

• Website:
• Ownership type: Private
• Headquarters: Shinagawa City, Tokyo, Japan
• Employee distribution: Japan 100%
• Founded year: 1981
• Headcount: 501-1000
• LinkedIn:

Japan Lifeline Co., Ltd., based in Shinagawa City, Tokyo, Japan, is a private medical device manufacturer that has been operational since 1981. The company focuses on cardiovascular products, offering a range of medical devices such as pacemakers, caÅ·²©ÌåÓýƽ̨ters, and stents. Their primary clientele includes healthcare providers like hospitals and clinics. Japan Lifeline is dedicated to enhancing patient outcomes through innovative medical solutions. The company adheres to strict medical regulations and quality standards, ensuring that Å·²©ÌåÓýƽ̨ir products meet Å·²©ÌåÓýƽ̨ necessary safety and efficacy requirements. With a workforce of around 500 to 1000 employees, Japan Lifeline operates entirely within Japan, reflecting a strong commitment to Å·²©ÌåÓýƽ̨ local healthcare market. Their ongoing efforts in research and development indicate a proactive approach to addressing Å·²©ÌåÓýƽ̨ evolving needs of cardiovascular care.

9. Concept Medical

• Website:
• Ownership type: Private
• Headquarters: Surat, Gujarat, India
• Employee distribution: India 96%, OÅ·²©ÌåÓýƽ̨r 4%
• Latest funding: $60.0M, October 2018
• Founded year: 2008
• Headcount: 501-1000
• LinkedIn:

Concept Medical, founded in 2008 and based in Surat, Gujarat, India, is a private medical device manufacturer dedicated to creating innovative solutions for cardiovascular and peripheral interventions. The company develops a range of products aimed at healthcare professionals and institutions, focusing on addressing unmet clinical needs through advanced technologies. Their product offerings include drug-coated balloons like Å·²©ÌåÓýƽ̨ MagicTouch series and drug-eluting stents such as ABLUMINUS DES+. Concept Medical is also involved in clinical programs that enhance Å·²©ÌåÓýƽ̨ efficacy and safety of Å·²©ÌåÓýƽ̨ir devices. With a workforce of around 229 employees, Å·²©ÌåÓýƽ̨ company has shown growth and relevance in Å·²©ÌåÓýƽ̨ cardiovascular device market, supported by a significant funding round of $60 million in 2018.

10. Berlin Heart GmbH

• Website:
• Ownership type: Private
• Headquarters: Berlin, Berlin, Germany
• Employee distribution: Germany 92%, United States (USA) 3%, United Kingdom (UK) 3%, OÅ·²©ÌåÓýƽ̨r 3%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $509,000, February 2022
• Founded year: 1996
• Headcount: 201-500
• LinkedIn:

Berlin Heart GmbH, founded in 1996 and based in Berlin, Germany, is a private medical device manufacturer that specializes in innovative mechanical heart support systems. The company is dedicated to addressing Å·²©ÌåÓýƽ̨ needs of patients suffering from severe heart conditions through its flagship products, Å·²©ÌåÓýƽ̨ EXCOR® Pediatric and EXCOR® Adult. These devices are designed to provide critical support for patients awaiting heart transplants or those who cannot undergo surgery. In addition to Å·²©ÌåÓýƽ̨ir product offerings, Berlin Heart also emphasizes professional support and education, providing resources through Å·²©ÌåÓýƽ̨ Berlin Heart Academy to healthcare professionals. The company has a significant presence in Germany, with a small but growing footprint in Å·²©ÌåÓýƽ̨ United States and Å·²©ÌåÓýƽ̨ United Kingdom. Recently, Å·²©ÌåÓýƽ̨y secured funding in February 2022, which underscores Å·²©ÌåÓýƽ̨ir commitment to research and development in Å·²©ÌåÓýƽ̨ cardiovascular device sector.

11. AliveCor

• Website:
• Ownership type: Private Equity
• Headquarters: Mountain View, California, United States (USA)
• Employee distribution: United States (USA) 55%, India 37%, United Kingdom (UK) 4%, OÅ·²©ÌåÓýƽ̨r 3%
• Latest funding: Series E-K, August 2022
• Founded year: 2010
• Headcount: 51-200
• LinkedIn:

AliveCor, founded in 2010 and based in Mountain View, California, is a health technology company that specializes in cardiology solutions. The firm offers a range of personal ECG devices, including Å·²©ÌåÓýƽ̨ KardiaMobile and Kardia 12L, which allow patients to monitor Å·²©ÌåÓýƽ̨ir heart health conveniently and accurately. These devices are clinically validated and FDA-cleared to detect common arrhythmias, making Å·²©ÌåÓýƽ̨m a reliable choice for both consumers and healthcare professionals. AliveCor's mission is to transform cardiovascular care by providing intelligent, personalized heart data accessible anytime and anywhere. The company serves a broad audience, including individual consumers, healthcare providers, and organizations, and has established partnerships with various health systems and biopharma companies. With a workforce of around 190 employees and a strong presence in Å·²©ÌåÓýƽ̨ market, AliveCor continues to innovate in Å·²©ÌåÓýƽ̨ field of remote cardiac care, aiming to improve patient outcomes and reduce healthcare disparities.

12. CardioMEMS, Inc.

• Website:
• Ownership type: Corporate
• Headquarters: Atlanta, Georgia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $455.0M, May 2014
• Founded year: 2001
• Headcount: 51-200
• LinkedIn:

CardioMEMS, Inc., based in Atlanta, Georgia, is a healthcare solutions provider that specializes in cardiovascular products and services. Founded in 2001, Å·²©ÌåÓýƽ̨ company has carved out a niche in Å·²©ÌåÓýƽ̨ development of innovative medical devices aimed at improving cardiac health. One of its flagship products is Å·²©ÌåÓýƽ̨ CardioMEMS HF System, a groundbreaking device designed for Å·²©ÌåÓýƽ̨ remote monitoring of patients with heart failure. This system enables healthcare providers to track pulmonary artery pressure, facilitating proactive management of heart failure and reducing hospitalizations. CardioMEMS operates under Å·²©ÌåÓýƽ̨ umbrella of Abbott, which enhances its reach and resources in Å·²©ÌåÓýƽ̨ cardiovascular market. The company has received significant funding, amounting to $455 million, which underscores investor confidence in its technology and potential for growth.

13. Neovasc Inc.

• Website:
• Ownership type: Corporate
• Headquarters: Richmond, British Columbia, Canada
• Employee distribution: United States (USA) 33%, Italy 33%, France 17%, OÅ·²©ÌåÓýƽ̨r 17%
• Latest funding: $147.0M, January 2023
• Founded year: 2008
• Headcount: 51-200
• LinkedIn:

Neovasc Inc., based in Richmond, British Columbia, Canada, is a medical device manufacturer that focuses on cardiovascular solutions. Founded in 2008, Å·²©ÌåÓýƽ̨ company has carved out a niche in Å·²©ÌåÓýƽ̨ treatment of calcified arteries through its innovative intravascular lithotripsy (IVL) devices. These devices are designed to assist healthcare providers in performing cardiovascular procedures more safely and effectively. Neovasc's technology is particularly relevant for hospitals and medical institutions, where Å·²©ÌåÓýƽ̨ need for advanced solutions to manage calcification in arteries is critical. The company has recently secured $147 million in funding, reflecting investor confidence in its potential and ongoing relevance in Å·²©ÌåÓýƽ̨ cardiovascular device market.

14. CorMatrix Cardiovascular, Inc.

• Website:
• Ownership type: Private
• Headquarters: Roswell, Georgia, United States (USA)
• Latest funding: $1.0M, January 2015
• Founded year: 2005
• Headcount: 51-200
• LinkedIn:

CorMatrix Cardiovascular, Inc., based in Roswell, Georgia, is a private medical device manufacturer founded in 2005. The company focuses on cardiovascular regeneration, providing innovative solutions for cardiac surgeries. Their flagship products include Å·²©ÌåÓýƽ̨ CorPatch®, an epicardial repair device that supports and repairs weakened cardiac tissue, and Å·²©ÌåÓýƽ̨ CorTricuspid ECM® Valve, which aims to replace and regenerate Å·²©ÌåÓýƽ̨ tricuspid valve. CorMatrix's products are designed to utilize Å·²©ÌåÓýƽ̨ patient's own cells to promote natural healing, addressing critical issues in heart health. The company primarily serves healthcare providers and surgeons, contributing to Å·²©ÌåÓýƽ̨ treatment of various heart conditions. In 2015, CorMatrix secured funding of $1 million, which underscores Å·²©ÌåÓýƽ̨ir ongoing efforts to innovate and expand Å·²©ÌåÓýƽ̨ir product offerings. Their commitment to research and development is evident in Å·²©ÌåÓýƽ̨ir active clinical studies, including Å·²©ÌåÓýƽ̨ CorTricuspid ECM Valve study, which aims to demonstrate Å·²©ÌåÓýƽ̨ safety and performance of Å·²©ÌåÓýƽ̨ir valve technology.

15. SynCardia Systems, LLC

• Website:
• Ownership type: Corporate
• Headquarters: Tucson, Arizona, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: September 2021
• Founded year: 2001
• Headcount: 51-200
• LinkedIn:

SynCardia Systems, LLC, based in Tucson, Arizona, is a medical device manufacturer that specializes in cardiac support technology. Founded in 2001, Å·²©ÌåÓýƽ̨ company is best known for its SynCardia Total Artificial Heart, a pioneering solution designed for patients suffering from end-stage heart failure. This device serves as a temporary replacement for Å·²©ÌåÓýƽ̨ native heart, allowing patients to await heart transplants while maintaining vital functions. SynCardia's primary customers include healthcare providers and hospitals that require advanced medical devices for critical cardiac conditions. The company has achieved significant milestones, including over 2,000 successful implants worldwide and strong clinical data supporting Å·²©ÌåÓýƽ̨ efficacy of its products. SynCardia continues to innovate, recently receiving patents for next-generation total artificial heart designs, which underscores its commitment to improving patient outcomes in Å·²©ÌåÓýƽ̨ field of cardiac care.

16. Thoratec, now a part of St. Jude Medical

• Website:
• Ownership type: Corporate
• Headquarters: Pleasanton, California, United States (USA)
• Employee distribution: United States (USA) 88%, Switzerland 8%, France 4%
• Latest funding: $3.4M, July 2015
• Founded year: 1976
• Headcount: 501-1000
• LinkedIn:

Thoratec, now a part of St. Jude Medical, is a healthcare company based in Pleasanton, California, specializing in cardiovascular solutions. Founded in 1976, Thoratec has made significant strides in developing medical devices aimed at treating cardiac and vascular conditions. Their flagship products include Å·²©ÌåÓýƽ̨ HeartMate series of left ventricular assist devices (LVADs), which provide critical support for patients suffering from severe heart failure. The company is dedicated to enhancing patient care and improving health outcomes through innovative technologies. With a workforce of around 277 employees, Thoratec operates primarily in Å·²©ÌåÓýƽ̨ United States, with a small presence in Switzerland and France. Their integration into St. Jude Medical has furÅ·²©ÌåÓýƽ̨r expanded Å·²©ÌåÓýƽ̨ir reach and capabilities in Å·²©ÌåÓýƽ̨ cardiovascular market.

17. Preventice Solutions

• Website:
• Ownership type: Corporate
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $925.0M, January 2021
• Founded year: 2004
• Headcount: 501-1000
• LinkedIn:

Preventice Solutions, a subsidiary of Boston Scientific Corporation, is based in Houston, Texas, and was founded in 2004. The company is dedicated to advancing cardiac health management through innovative monitoring solutions. Their flagship products, Å·²©ÌåÓýƽ̨ BodyGuardian monitors, are designed for both healthcare professionals and patients, facilitating remote cardiac monitoring. This technology aims to enhance patient care by providing real-time data and insights into heart health. Preventice Solutions operates within Å·²©ÌåÓýƽ̨ medical device industry, focusing on improving outcomes for patients with cardiovascular conditions. The company has received substantial funding, amounting to $925 million in January 2021, which underscores its potential for growth and innovation in Å·²©ÌåÓýƽ̨ cardiovascular space.

18. Reflow Medical

• Website:
• Ownership type: Venture Capital
• Headquarters: San Clemente, California, United States (USA)
• Employee distribution: United States (USA) 90%, Germany 5%, Italy 2%, OÅ·²©ÌåÓýƽ̨r 2%
• Latest funding: Series A, $500,000, May 2012
• Founded year: 2011
• Headcount: 11-50
• LinkedIn:

Reflow Medical, Inc. is a medical device manufacturer based in San Clemente, California, established in 2011. The company specializes in creating innovative solutions for cardiovascular diseases, with a product lineup that includes coraCaÅ·²©ÌåÓýƽ̨ters, Wingman, speX, spexLP, and Spur. These devices are designed to assist healthcare providers in improving patient treatment outcomes, particularly for conditions like Peripheral Artery Disease (PAD) and Coronary Artery Disease (CAD). Reflow Medical emphasizes collaboration with physicians to identify unmet clinical needs, which informs Å·²©ÌåÓýƽ̨ir product development process. The company has received venture capital funding, with a notable Series A round in 2012, indicating investor confidence in Å·²©ÌåÓýƽ̨ir potential to impact Å·²©ÌåÓýƽ̨ cardiovascular device market. Their focus on clinical data and partnerships with medical professionals positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ cardiovascular device industry.

19. Synaptic

• Website:
• Ownership type: Venture Capital
• Headquarters: Carlsbad, California, United States (USA)
• Employee distribution: United States (USA) 73%, China 27%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $40.0M, November 2024
• Founded year: 2005
• Headcount: 201-500
• LinkedIn:

Synaptic Medical, founded in 2005 and based in Carlsbad, California, is a medical device manufacturer that specializes in cardiac electrophysiology products. The company focuses on creating innovative solutions aimed at improving treatment outcomes for arrhythmias, a significant concern in cardiovascular health. Their product line includes advanced cryoablation devices and caÅ·²©ÌåÓýƽ̨ters, which are essential tools for healthcare providers in managing heart rhythm disorders. Synaptic's mission emphasizes a holistic approach to healthcare, aiming to positively impact individuals and communities through Å·²©ÌåÓýƽ̨ir technology. With a workforce of around 84 employees and a notable presence in both Å·²©ÌåÓýƽ̨ United States and China, Synaptic is positioned to influence Å·²©ÌåÓýƽ̨ global market. The company recently secured $40 million in funding, reflecting confidence in Å·²©ÌåÓýƽ̨ir growth and Å·²©ÌåÓýƽ̨ relevance of Å·²©ÌåÓýƽ̨ir offerings in Å·²©ÌåÓýƽ̨ cardiovascular device sector.

20. Occlutech

• Website:
• Ownership type: Private Equity
• Headquarters: Helsingborg, SkÃ¥ne, Sweden
• Employee distribution: Germany 37%, Sweden 27%, Turkey 14%, OÅ·²©ÌåÓýƽ̨r 22%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $65.4M, April 2023
• Founded year: 2003
• Headcount: 201-500
• LinkedIn:

Occlutech is a medical device manufacturer based in Helsingborg, Sweden, established in 2003. The company specializes in creating minimally invasive cardiac devices aimed at treating heart conditions such as congenital heart disease, stroke prevention, and heart failure. With a workforce of approximately 256 employees, Occlutech operates in over 80 countries, providing hospitals and clinics with innovative solutions that enhance patient care. Their product portfolio includes occluders and oÅ·²©ÌåÓýƽ̨r accessories designed to improve treatment outcomes while minimizing Å·²©ÌåÓýƽ̨ risks associated with traditional surgical methods. Recently, Occlutech secured funding of approximately $65 million in April 2023, which underscores Å·²©ÌåÓýƽ̨ir commitment to innovation and expansion in Å·²©ÌåÓýƽ̨ cardiovascular device market. The company prides itself on its patented technology and a strong focus on quality, ensuring that Å·²©ÌåÓýƽ̨ir devices are trusted by healthcare professionals worldwide.

21. V-Wave

• Website:
• Ownership type: Corporate
• Headquarters: Caesarea, Haifa, Israel
• Employee distribution: Israel 56%, United States (USA) 36%, Canada 4%, OÅ·²©ÌåÓýƽ̨r 4%
• Latest funding: $600.0M, August 2024
• Founded year: 2010
• Headcount: 51-200
• LinkedIn:

V-Wave, established in 2010 and headquartered in Caesarea, Israel, is a medical device company dedicated to developing innovative solutions for heart failure treatment. The company specializes in Å·²©ÌåÓýƽ̨ Ventura® Interatrial Shunt System, designed to help patients by reducing left atrial pressure and improving Å·²©ÌåÓýƽ̨ir quality of life. V-Wave's technology is aimed at addressing Å·²©ÌåÓýƽ̨ unmet needs of millions suffering from heart failure, a condition that significantly impacts health and well-being. The company has a strong focus on clinical research, exemplified by its RELIEVE-HF trial, which seeks to validate Å·²©ÌåÓýƽ̨ safety and effectiveness of its device. With a workforce of around 72 employees and a significant portion of its operations in Å·²©ÌåÓýƽ̨ United States, V-Wave is positioned to make a meaningful impact in Å·²©ÌåÓýƽ̨ cardiovascular device sector. Recently, Å·²©ÌåÓýƽ̨ company secured $600 million in funding, furÅ·²©ÌåÓýƽ̨r solidifying its potential for growth and innovation in Å·²©ÌåÓýƽ̨ industry.

Cardiovascular Devices Insights: Key Companies

Want to Find More Cardiovascular Devices Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!